Walgreens Boots Alliance, Inc.

WBA

US9314271084

Drug Retailers

Real-time Estimate Cboe BZX Other stock markets 10:47:56 2025-01-22 am EST			5-day change	1st Jan Change
11.24 ^USD	-1.10%		-10.10%	+20.74%

Jan. 21	Equity Markets Rise as Traders Weigh Trump's Agenda Items	MT
Jan. 21	Equity Markets Rise as Traders Weigh Trump's Agenda Items	MT

Walgreens Boots Alliance, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2024

January 10, 2025 at 07:00 am EST

Walgreens Boots Alliance, Inc. reported earnings results for the first quarter ended November 30, 2024. For the first quarter, the company reported sales was USD 39,459 million compared to USD 36,707 million a year ago. Net loss was USD 265 million compared to USD 67 million a year ago.

Basic loss per share from continuing operations was USD 0.31 compared to USD 0.08 a year ago. Diluted loss per share from continuing operations was USD 0.31 compared to USD 0.08 a year ago.

Latest news about Walgreens Boots Alliance, Inc.

Equity Markets Rise as Traders Weigh Trump's Agenda Items	Jan. 21	MT
Equity Markets Rise as Traders Weigh Trump's Agenda Items	Jan. 21	MT
Sector Update: Health Care Stocks Higher Late Afternoon	Jan. 21	MT
Sector Update: Health Care	Jan. 21	MT
Equity Markets Higher Following Trump's Inauguration; Netflix Results Due	Jan. 21	MT
Walgreens Boots Alliance Shares Fall Amid US DOJ Lawsuit on Alleged Improper Dispensing of Opioids	Jan. 21	MT
Walgreens Boots Alliance Shares Fall Amid US DoJ's Lawsuit on Alleged Improper Dispensing of Opioids	Jan. 21	MT
Walgreens Shares Fall After Justice Department Files Opioid Lawsuit	Jan. 17	DJ
U.S. Sues Walgreens For Role in Opiod Crisis	Jan. 17	DJ
Truist Securities Adjusts Walgreens Boots Alliance Price Target to $13 From $10, Maintains Hold Rating	Jan. 16	MT
Walgreens Boots Alliance Showing Turnaround Progress, RBC Says	Jan. 15	MT
Wall Street rallies on inflation and earnings bonanza	Jan. 15
RBC Raises Price Target on Walgreens Boots Alliance to $12 From $9, Keeps Sector Perform Rating	Jan. 15	MT
Analyst recommendations: Adobe, Intuit, XPO, Netflix, Tesla...	Jan. 15
HSBC Adjusts Walgreens Boots Alliance's Price Target to $10 From $7.60, Keeps Reduce Rating	Jan. 14	MT
Jefferies Adjusts Walgreens Boots Alliance Price Target to $11 From $9	Jan. 13	MT
TD Cowen Adjusts Price Target on Walgreens Boots Alliance to $15 From $14	Jan. 13	MT
Deutsche Bank Adjusts Walgreens Boots Alliance Price Target to $11 From $10, Maintains Hold Rating	Jan. 13	MT
North American Morning Briefing : Stock Futures Down As Rate Cut Hopes Fade	Jan. 13	DJ
Equities Retreat, Yields Surge as Markets Weigh Jobs Report	Jan. 10	MT
Equities Retreat, Yields Surge as Markets Weigh Jobs Report	Jan. 10	MT
Sector Update: Health Care Stocks Weaker Late Afternoon	Jan. 10	MT
Equities Fall, Yields Soar Intraday After Jobs Data	Jan. 10	MT
Sector Update: Health Care Stocks Softer in Afternoon Trading	Jan. 10	MT
Sector Update: Health Care	Jan. 10	MT

Chart Walgreens Boots Alliance, Inc.

Duration

Period

WBA: Dynamic Chart

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (91% of net sales) and internationally (9%). At the end of August 2024, the activity is carried out through 12,248 outlets (of which 8,560 located in the United States, Puerto Rico and the US Virgin Islands), 464 healthcare locations and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84.1%), Germany (8.2%), the United Kingdom (6.5%) and other (1.2%).

Employees

252,500

Sector

Drug Retailers

Calendar

2025-01-30 - Annual General Meeting

More about the company